Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis

1.1 There is currently not enough evidence to recommend the routine adoption of the BCM – Body Composition Monitor to guide fluid management in people with chronic kidney disease having dialysis in the NHS. Further research is recommended to show the effect of using the BCM – Body Composition Monitor on clinical outcomes (see section 6.1).

Centres that are currently using the BCM – Body Composition Monitor to guide fluid management are encouraged to take part in research and data collection (see section 5.18).

Centres that do not currently use the BCM – Body Composition Monitor to guide fluid management should only do so as part of a research study, such as the BISTRO trial.

NICE will support this guidance through a range of activities to promote the recommendations for further research (see section 7).

1.2 There is currently not enough validation or clinical-outcome data to recommend the routine adoption of the InBody S10 or the MultiScan 5000 to guide fluid management in people with chronic kidney disease having dialysis in the NHS.